2019 annual financial data

ImmunityBio 2019 Financial results

Direct answer

Revenue was 43,000 USD.

Operating income was -66,907,000 USD and net income was -65,789,000 USD.
Operating cash flow was -152,109,000 USD.

Get free ImmunityBio email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
43,000 USD
Operating income
-66,907,000 USD
Net income
-65,789,000 USD
Operating cash flow
-152,109,000 USD